Emerging Science and Management of Atopic Dermatitis

Dec
2017
Vol. 36. No. 4

Introduction

The landscape of atopic dermatitis has evolved rapidly in recent years.

Emerging Science and Management of Atopic Dermatitis, Introduction

Lawrence F. Eichenfield, MD

The landscape of atopic dermatitis has evolved rapidly in recent years. The introduction of crisaborole, a  phosphodiesterase-4 inhibitor, enables clinicians to offer another nonsteroidal topical therapy to patients with mild to moderate disease. The approval of dupilumab—an interleukin-4 and interleukin-13 inhibitor and the first biologic to become available for the  treatment of atopic dermatitis—has revolutionized the therapy of adults with moderate to severe disease.

MORE

The Disease Burden of Atopic Dermatitis

Lawrence F. Eichenfield, MD | Linda Stein Gold, MD

The impact of atopic dermatitis on patients in terms of symptoms and quality of life has been well characterized in children and their families.

MORE

Systemic Therapy of Atopic Dermatitis: Welcome to the Revolution

Lawrence F. Eichenfield, MD | Linda Stein Gold, MD

Most patients with atopic dermatitis may be adequately managed with nonpharmacologic measures (eg, emollients), topical anti-inflammatory therapies, environmental modification (eg, avoiding triggers), and for some, phototherapy.

MORE